Market News / Story
Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
GlobeNewswire ·
GlobeNewswire reports: MELBOURNE, Australia and SAN FRANCISCO, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer, will present at the Canaccord Genuity Drug and Device Conference on Monday, October 12, 2026 at 3:50 p.m. AEST in Australia. At the conference,…
Related stories
China And The EU Have Come To An Agreement To Better Handle Trade DisputesRead story summary
China And The Eu Have Come To An Agreement To Better Handle Trade Disputes. China And The Eu Have Agreed On Hybrid Vehicle Trade Following Extensive Talks, In Line With Wto Rules. Discussions Will Continue On Price Terms And The Eu's Anti-subsidy Inquiry Into Chinese Electric Cars. China commerce ministry to keep exploring scope to cut tariffs on some goods under WTO rules
VIEW SOURCE